Direct Genetics Referral Pathway for High-Grade Serous Ovarian Cancer Patients: The "Opt-Out" Process.

McGee, Jacob; Peart, Teresa M; Foley, Norine; Bertrand, Monique; Prefontaine, Michel; Sugimoto, Akira; Ettler, Helen; Welch, Stephen; Panabaker, Karen

McGee, Jacob; Peart, Teresa M; Foley, Norine; Bertrand, Monique; Prefontaine, Michel; Sugimoto, Akira; Ettler, Helen; Welch, Stephen; Panabaker, Karen.

Afiliación

McGee J; Department of Obstetrics & Gynecology, London Health Sciences Centre, London, Canada.
Peart TM; Department of Obstetrics & Gynecology, London Health Sciences Centre, London, Canada.
Foley N; Department of Aging, Rehabilitation & Geriatric Care Program, Division of Stroke Rehabilitation and Assistive Technologies, Lawson Health Research Institute, London, Canada.
Bertrand M; Department of Obstetrics & Gynecology, London Health Sciences Centre, London, Canada.
Prefontaine M; Department of Obstetrics & Gynecology, London Health Sciences Centre, London, Canada.
Sugimoto A; Department of Obstetrics & Gynecology, London Health Sciences Centre, London, Canada.
Ettler H; Department of Pathology and Laboratory Medicine, London Health Sciences Centre, London, Canada.
Welch S; Department of Medical Oncology, London Health Sciences Centre, London, Canada.
Panabaker K; Department of Medical Genetics, London Health Sciences Centre, London, Canada.

J Oncol ; 2019: 6029097, 2019.

Article en En | MEDLINE | ID: mdl-31061661

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: J Oncol Año: 2019 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Egipto

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google